A proprietary topical delivery technology that provides short-acting mucosal pain relief during placement of an intrauterine device (IUD). The product has additional potential applicability to a range of other important women’s health procedures.
Lidbree is approved for commercial use in Europe and will be further developed for future market introduction in the United States.

Lidbree is not available for commercial sale in the United States.